BioRestorative Therapies, Inc.

( )
BRTX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. -1.05%540.551.0%$711.99m
DHRDanaher Corp. -1.50%278.050.7%$696.91m
ABTAbbott Laboratories -0.90%102.450.8%$573.17m
MDTMedtronic Plc -0.76%84.400.6%$552.43m
ISRGIntuitive Surgical, Inc. -1.83%197.700.8%$362.07m
SYKStryker Corp. -2.26%211.231.3%$308.54m
BSXBoston Scientific Corp. -1.55%40.661.0%$264.99m
BDXBecton, Dickinson & Co. -3.63%228.231.0%$264.35m
EWEdwards Lifesciences Corp. -1.13%86.450.4%$243.13m
DXCMDexCom, Inc. 4.53%95.211.9%$229.74m
ALGNAlign Technology, Inc. -2.82%222.366.4%$211.12m
AAgilent Technologies, Inc. -0.32%132.221.7%$196.73m
BAXBaxter International, Inc. -2.53%56.251.8%$169.93m
STESTERIS Plc (Ireland) -0.20%172.693.1%$148.14m
MTDMettler-Toledo International, Inc. 0.12%1203.945.9%$139.82m

Company Profile

Biorestorative Therapies Inc. provides stem cell collections, storage, and treatment services. It intends to develop a laboratory, performing cellular characterization and culturing, therapeutic outcomes analysis, stem cell-related IP and stem cell collection and storage services. The firm is developing the following scientific programs: brtxDISC, which offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures and ThermoStem, which involves the use of a cell-based, brown adipose tissue construct, treatment for metabolic disease, such as type 2 diabetes, obesity, hypertension, and other metabolic disorders, as well as cardiac deficiencies. Its products are sold under the BRTX-100, ThermoStem and Stem Pearls trademarks. The company was founded on June 13, 1997 and is headquartered in Melville, NY.